 Comparison heterotypic protection influenza vaccines viruses Children years families double-blind placebo-controlled study efficacy bivalent CR vaccine trivalent TI vaccine vaccines antigens vaccination geometric mean titer CR group TI group placebo group influenza CR recipients TI recipients placebo recipients influenza A/Taiwan TI vaccine heterotypic protection CR vaccine children years infection rate contrast children years CR vaccine protective TI